NIH-funded research R01 grant

Investigating a protein complex's role in immune system diseases and autoimmunity

Official title: WAVE Regulatory Complex in Primary Immunodeficiency Disease and autoimmunity

Funded at University of Washington · NIH-11019690 · Data updated 2026-11-12

This study is looking at how changes in a specific gene might affect the immune system in children with immune disorders, to help us understand and find better treatments for those who struggle to fight infections.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startFebruary 10, 2021
Project endJanuary 31, 2026
Funding year2025
Award (this year)$495,723
NIH project number5R01AI158353-05
Project IDNIH-11019690 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children under 11 years old who have been diagnosed with primary immunodeficiency diseases or exhibit symptoms of autoimmunity.

Less likely to help

Patients with well-defined primary immunodeficiency diseases that are not linked to the WAVE Regulatory Complex may not benefit from this research.

What this research studies

This research focuses on understanding the role of the WAVE Regulatory Complex in primary immunodeficiency diseases and autoimmunity, particularly in children. It aims to explore how mutations in the NCKAP1L gene affect the immune system's ability to respond to infections and produce antibodies. By using advanced techniques like CRISPR/Cas9 and mouse models, the researchers will investigate the specific functions of Hematopoietic protein-1 in immune cell development and function. This could lead to better understanding and potential treatments for severe immune deficiencies.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnosis and treatment options for children with primary immunodeficiency diseases and autoimmune conditions.

How similar studies have gone: While the specific approach of targeting the WAVE Regulatory Complex is novel, similar research has shown promise in understanding immune deficiencies and developing targeted therapies.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Iritani, Brian M — University of Washington
  • Study coordinator: Iritani, Brian M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.